Investors
Welcome to the investors section of ADOCIA
ADOCIA is a biotechnology company specialized in the development of best-in-class medicines with already approved therapeutic proteins.
Investor presentation
Download
Financial news
- 2013-04-26
Release of 2012 Reference Document (French only) - 2013-04-24
Q1 2013 revenues - 2013-04-23
Liquidity agreement (French only) - 2013-03-20
2012 Annual Results - 2013-02-19
ADOCIA reports a revenue multiplied by 2.5 with a strong cash position for 2012 - 2013-01-07
Adocia announces its financial calendar for 2013 as well as its participation to upcoming investor conferences - 2012-10-30
Adocia announces the strong growth of its turnover - 2012-09-24
Large & Midcap Event - 24-25 September 2012, Paris - 2012-09-04
SFAF meeting - Half year 2012 results. At 14:30, NYSE EURONEXT, room Auditorium - 3 rue Cambon - 75001 Paris - 2012-09-03
Financial results and business report for the first half of 2012 - 2012-09-03
- 2012-05-30
Additional contribution to Liquidity Agreement with Dexia Securities France (French only) - 2012-04-26
ADOCIA maintains its dynamic growth: revenue of 1st quarter 2012 - 2012-04-02
2011 annual financial results - 2011: a key milestone in ADOCIA's development - 2012-03-15
ADOCIA increases the size of its Initial Public Offering to E27.4 million through the partial... - 2012-03-15
Liquidity agreement with Dexia Securities France (French only) - 2012-02-29
ADOCIA reports strong growth in operating income in 2011 - 2012-02-14
ADOCIA carries out, with much success, the first IPO of the year... - 2012-01-26
ADOCIA launches its IPO on the NYSE Euronext regulated market in Paris - 2012-01-18
ADOCIA announces the registration of its Document de base (French only)
Next events
Home Page | ADOCIA | BioChaperone® | Products | Partnering | Investors | News | Careers
copyright ADOCIA©2011 - Terms of use - Contact
Follow us 
